These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3144526)

  • 1. Selection of resistance by piperacillin during Pseudomonas aeruginosa endocarditis.
    Letendre ED; Mantha R; Turgeon PL
    J Antimicrob Chemother; 1988 Oct; 22(4):557-62. PubMed ID: 3144526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of therapy in pseudomonas endocarditis: selection of resistant mutants.
    Jimenez-Lucho VE; Saravolatz LD; Medeiros AA; Pohlod D
    J Infect Dis; 1986 Jul; 154(1):64-8. PubMed ID: 3486925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
    Nishida K; Higashitani F; Hyodo A
    Chemotherapy; 1997; 43(3):171-8. PubMed ID: 9142457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.
    Jacobs JY; Livermore DM; Davy KW
    J Antimicrob Chemother; 1984 Sep; 14(3):221-9. PubMed ID: 6436226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of Pseudomonas aeruginosa to piperacillin resistance mediated by beta-lactamase production.
    Bell SM; Pham JN; Lanzarone JY
    J Antimicrob Chemother; 1985 Jun; 15(6):665-70. PubMed ID: 3928573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
    Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of piperacillin/tazobactam against 615 Pseudomonas aeruginosa strains isolated in intensive care units.
    Bonfiglio G; Laksai Y; Franceschini N; Perilli M; Segatore B; Bianchi C; Stefani S; Amicosante G; Nicoletti G
    Chemotherapy; 1998; 44(5):305-12. PubMed ID: 9732144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
    Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
    Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of beta-lactamase in Pseudomonas aeruginosa as studied by HPLC.
    de Neeling AJ; Rutgers A; Schot CS; Stobberingh EE
    J Antimicrob Chemother; 1988 Nov; 22(5):613-21. PubMed ID: 3145265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O; Giwercman B; Pedersen SS; Høiby N
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin with and without tazobactam against extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in a rat thigh abscess model.
    Karadenizli A; Mutlu B; Okay E; Kolayli F; Vahaboglu H
    Chemotherapy; 2001; 47(4):292-6. PubMed ID: 11399866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Fujimura S; Takane H; Nakano Y; Watanabe A
    J Antimicrob Chemother; 2009 Nov; 64(5):1115-6. PubMed ID: 19744981
    [No Abstract]   [Full Text] [Related]  

  • 18. Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa.
    Edgeworth JD; Merante D; Patel S; Young C; Jones P; Vithlani S; Wyncoll D; Roberts P; Jones A; Den Nagata T; Ariyasu M; Livermore DM; Beale R
    Clin Infect Dis; 2019 May; 68(11):1932-1934. PubMed ID: 30418554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates of Pseudomonas aeruginosa].
    Zarakolu P; Metan G; Gürkan Aydin N; Altun B; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Jul; 41(3):363-7. PubMed ID: 17933246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in resistance of Pseudomonas aeruginosa to beta-lactams in a general intensive care unit over a three-year period. Role of piperacillin].
    Bercault N; Martin P; Demasure M; Poisson D; Gueveler C
    Pathol Biol (Paris); 1991 Feb; 39(2):105-9. PubMed ID: 1901983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.